Guanfacine Safety in Bicuspid Aortic Valve with Aortic Stenosis

Key Management Principles

The American College of Cardiology recommends that hypertension should be treated with pharmacotherapy in adults with asymptomatic aortic stenosis, starting at low doses and gradually titrating upward 1, 2.
The combination of hypertension and aortic stenosis creates "2 resistors in series," which increases the rate of cardiovascular complications 1, 2.
In patients with asymptomatic mild-to-moderate aortic stenosis, hypertension is associated with more abnormal left ventricular structure and increased cardiovascular morbidity and mortality 1, 2.

Guanfacine is an alpha-2 agonist that lowers blood pressure through central mechanisms, reducing sympathetic outflow 1.
Unlike beta blockers, guanfacine does not directly slow heart rate through beta-receptor blockade, though it may have modest heart rate effects through central mechanisms 1.
There are no specific contraindications to guanfacine use in valvular heart disease in current guidelines from the American College of Cardiology 1, 2.

RAS blockade (ACE inhibitors or ARBs) may be advantageous due to potentially beneficial effects on left ventricular fibrosis, control of hypertension, reduction of dyspnea, and improved effort tolerance 1, 2.
Nitroprusside infusion in hypertensive patients with severe aortic stenosis has been shown to lower pulmonary and systemic resistance with improvements in stroke volume and left ventricular end-diastolic pressure 1, 2.

Patients with bicuspid aortic valve require initial transthoracic echocardiography to evaluate valve morphology, measure severity of stenosis and regurgitation, and assess aortic dimensions 3, 4.
Serial evaluation of aortic dimensions is recommended when the aortic diameter exceeds 4.0 cm, with annual imaging when diameter exceeds 4.5 cm 4.
In patients with moderate or severe aortic stenosis, consultation or co-management with a cardiologist is preferred for hypertension management 1, 2.

Avoid excessive blood pressure reduction that could compromise coronary perfusion, particularly in severe aortic stenosis 1, 2.
Start antihypertensive therapy at low doses and titrate gradually to avoid precipitous drops in blood pressure 1, 2.
Monitor for symptoms of hypotension, particularly orthostatic symptoms, as guanfacine can cause these side effects 1.
First-degree relatives of patients with bicuspid aortic valve should be screened with echocardiography for valve disease and aortopathy 5.